[go: up one dir, main page]

WO2022180620A1 - Valve endo-urétrale - Google Patents

Valve endo-urétrale Download PDF

Info

Publication number
WO2022180620A1
WO2022180620A1 PCT/IB2022/051757 IB2022051757W WO2022180620A1 WO 2022180620 A1 WO2022180620 A1 WO 2022180620A1 IB 2022051757 W IB2022051757 W IB 2022051757W WO 2022180620 A1 WO2022180620 A1 WO 2022180620A1
Authority
WO
WIPO (PCT)
Prior art keywords
endo
urethral valve
slit
central portion
tubular portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2022/051757
Other languages
English (en)
Inventor
Tommaso MAZZOCCHI
Gioia LUCARINI
Leonardo MARZIALE
Novello PINZI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Relief Srl
Original Assignee
Relief Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Relief Srl filed Critical Relief Srl
Publication of WO2022180620A1 publication Critical patent/WO2022180620A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2476—Valves implantable in the body not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
    • A61F2/0022—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse placed deep in the body opening
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0071—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof thermoplastic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004—Rounded shapes, e.g. with rounded corners
    • A61F2230/001—Figure-8-shaped, e.g. hourglass-shaped
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001—Designing or manufacturing processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers

Definitions

  • the present invention relates to an endo-urethral valve, i.e. to an artificial endo-urethral sphincter, to be used by male patients suffering from urinary incontinence.
  • the invention relates to an endo-urethral valve configured to resiliently open under the effect of a compression force applied by the patient on his own penis at the position of the implant of the endo- urethral valve, in order to allow the urine to flow through the urethra and to empty the bladder, the endo-urethral valve also configured to resiliently close upon releasing the compression force.
  • US 4,968,294 describes an endo-urethral valve made of silicone and comprising a tubular urine inlet end portion and a tubular outlet end portions aligned to each other along a longitudinal axis of the endo-urethral valve. Between the inlet and outlet end portions, a substantially spherical central hollow portion is provided communicating with the inlet and outlet end portions through urine inlet and outlet passages, respectively.
  • the central portion contains a stopper portion comprising two sealing lips. The sealing lips symmetrically protrude from respective regions of the inner wall of the central hollow portion close to the outlet passage and extend towards the inlet passage of the spherical central hollow portion.
  • US 7,008,372 describes an endo-urethral valve comprising a first cylindrical case part configured to engage with the inner urethra walls and a smaller second cylindrical case part arranged coaxially and in hydraulic connection of the first case portion, as a longitudinal extension thereof.
  • a stopper body is arranged within the second case part and includes a cylindrical montage portion fluid-tightly mounted within the second case part and a stopper portion comprising a plurality of walls extending from the montage portion within the second case part towards the first case part.
  • the walls converge to form a normally closed cross-shaped slit that can be opened by compressing the second case part of the endo-urethral valve from outside.
  • the stopper portion includes a couple of relatively thin resilient lips forming a sort of duckbill pointing to the proximal portion of the endo-urethral valve, i.e. to the inlet of the urine. Due to this arrangement, the urine pressure insisting on the inlet side of the lips must be overcome in order to open the endo-urethral valve.
  • a silicone flat disc-shaped stopper portion comprising a peripheral ring fluid-tightly mounted in the central portion of the endo-urethral valve, and a plurality of circular sector-shaped stopper elements extending from the peripheral ring towards the longitudinal axis of the endo- urethral valve along a plane containing the peripheral ring.
  • the stopper elements are fluid-tightly adjacent to one another thus blocking any urine flow through the endo-urethral valve.
  • US 6,022,312 describes an endosphincter comprising a fastening part to be connected at an inner position of the urethra close to the natural sphincter, and a hollow cylindrical valve body distally extending from the fixing portion to be arranged within a distal portion of the urethra.
  • the valve body includes a stopper comprising sealing lips that, also in this case, can be resiliently brought from a closed undeformed configuration to an open deformed configuration by externally compressing the valve body, through the tissues of the penis.
  • the endo-urethral valves of US 4,968,294, US 4,932,938 and US 7,008,372 include a stopper structure formed by such thin wall stopper elements as lips converging towards the inlet portion of the device and normally kept at an edge-to-edge contact to each other along a seal line. In this condition, a substantially unidimensional seal is formed between the stopper elements, which bend therefore according to a substantially unpredictable elastic collapse mode whenever an opening compression force is applied from the outside.
  • a further object of the invention is to provide such an endo-urethral valve that is easy to be introduced and extracted from the urethra by the surgeon, without any risks to break the endo-urethral valve within the urethra. [0022] It is also an object of the invention to provide a method to manufacture such an endo-urethral valve.
  • an endo-urethral valve comprises: a proximal tubular portion and a distal tubular portion arranged along a common longitudinal axis and configured to anchor within a male patient’s urethra and allow a urine to flow therethrough; a central portion arranged between the proximal tubular portion and the distal tubular portion and configured to be pressed by the patient, in order to resiliently change from a closed undeformed configuration to an open deformed configuration, in which the central portion fluid-tightly separates or hydraulically connects, respectively, the proximal tubular portion and the distal tubular portion, wherein the central portion of the endo-urethral valve, in the closed undeformed configuration, has a central transversal dimension radially changing between a maximum central transversal dimension and a minimum central transversal dimension shorter than said maximum central transversal dimension, wherein the central portion includes a solid stopper body having a proximal side and a distal side mutually spaced
  • the through slit having walls mutually facing, wherein the walls - in the closed undeformed configuration, are fluid-tightly in contact to each other along the longitudinal extension of the stopper body; are configured to become spaced apart from each other forming a tubular duct along all said longitudinal extension when the central portion changes from the closed undeformed configuration to the open deformed configuration.
  • variable central transversal dimension the patient can easily find out in which radial direction he has to press his penis in order to open the endo-urethral valve, without making several attempts, which would be discomfortable.
  • the longitudinal extension of the stopper body allows the stopper body to be deformed in a more predictable way upon pressing it from outside, forming a tubular passage or duct having a predetermined length, and the stopper body is more likely to return to its original configuration upon releasing the external compression, without unexpected reclosure errors.
  • the solid stopper body and the slit along all its longitudinal extension, when the patient presses the resilient solid cylindrical segment in a plane containing the slit, the slit turns from a configuration in which the walls are in contact with each other fluid-tightly, to a configuration in which the walls form a tubular duct, which permits the passage of urine.
  • the user can simply press his penis using two fingers, thus obtaining such deformation.
  • the central portion consists of a resilient solid cylindrical segment having the longitudinal extension and having the through slit extending for all the longitudinal extension arranged in such a way that, when the patient presses the resilient solid cylindrical segment in a plane containing the slit, the slit turns from a configuration in which the walls are in contact with each other fluid-tightly, to a configuration in which the walls form the tubular duct.
  • Two ways to obtain the variable central transversal dimension of the central portion of the endo-urethral valve are described hereinafter, in connection to corresponding non-limitative embodiments of the stopper body.
  • an outer surface of the central portion has a couple of diametrically opposite protrusions with respect to the longitudinal axis, the protrusions having respective top portions at a predetermined height with respect to an outer surface of the central portion, a diametrical distance between the top portions providing the maximum central transversal dimension.
  • the protrusions extend parallel to the longitudinal axis of the endo-urethral valve to be more easily identified by the patient.
  • a minimum non limitative practical value of the height of the protrusion, above the outer surface of the central portion is about 1 mm.
  • the central portion of the endo-urethral valve is a biaxisymmetric central portion in which the shape of a cross section thereof has a major symmetry axis and a minor symmetry axis orthogonal to each other, said major symmetry axis providing said maximum central transversal dimension.
  • the cross section is a substantially elliptical cross section.
  • the through slit in the closed undeformed configuration, has a linear cross section substantially aligned to the maximum central transversal dimension of the central portion of the endo-urethral valve.
  • the cross- section of the slit is substantially aligned to the diametrically opposite protrusions of the central portion or is aligned to the major symmetry axis of the cross section of the central portion.
  • Such a shape and orientation of the cross-section of the slit make it easier to spread apart the walls of the slit and the assists a ready opening the endo-urethral valve under the action of the compression force by the patient on the central portion of the endo-urethral valve through the tissues of its own penis and the wall of the urethra.
  • the compression force required to open the slit can be more easily and precisely predicted as the critical compressive force by exceeding which a condition of elastic instability of the slit is triggered, as in the case of the buckling of a compressed beam.
  • the transversal size of the through slit in the closed configuration, is set between 4 and 6 mm, i.e. large enough to allow an easy passage of urine when the through slit is opened to form a tubular duct by compression from outside.
  • transversal size S is about 5 mm.
  • the longitudinal extension of the solid stopper body which is also the longitudinal extension of the through slit, is longer than the transversal size of the through slit.
  • the length of the solid stopper body, which is also the longitudinal extension of the through slit is set between 6 and 20 mm, i.e., large enough to be easily grasped by two fingers of the patient.
  • the proximal tubular portion and the distal tubular portion have an end transversal dimension larger than the maximum central transversal dimension.
  • proximal and distal end portions of the endo-urethral valve can easily be stabilized at a predetermined position along the urethra, in other words, the larger size of proximal and distal end portions prevents the endo-urethral valve from migrating through the urethra, and to be possibly expelled therefrom.
  • the proximal tubular portion and the distal tubular portion have an axisymmetric shape, with respect to the longitudinal axis.
  • at least the external surfaces of the proximal tubular portion and the distal tubular portion have a cylindrical shape.
  • the proximal and distal tubular portions comprise respective cylindrical shells. Such a shape is also preferred because it makes easier to insert/extract the endo-urethral valve into/from the patient’s urethra.
  • an endo-urethral valve can be housed in the patient’s urethra without particular discomfort to the patient. Even if the endo- urethral valve, once it has been introduced into the patient’s urethra, were to rotate about its own longitudinal axis, in particular if the outer surfaces of the end portions are cylindrical, the required compression force direction would be in any case easy to be identified by the patient when opening the endo-urethral valve.
  • a proximal/distal tubular connection portion having a cross-section that longitudinally change in a gradual way from an axisymmetric shape of the proximal and/or distal tubular portion(s) and the shape of the central portion having a major symmetry axis and a minor symmetry axis.
  • the walls of the through slit, in the closed undeformed configuration are fluid-tightly in contact to each other at a distal part of the longitudinal extension of the solid stopper body, whereas at a proximal part of the longitudinal extension of the solid stopper body, they are spaced apart from each other by a gap, and a width of said gap decreases towards the distal part.
  • the above-mentioned gap is regularly filled with urine. Therefore, an increasing urine pressure is exerted on the lateral walls of the gap itself, i.e., on the proximal part of the mutually facing walls of the through slit.
  • the urine pressure depends upon the amount of urine progressively accumulated in the bladder.
  • the endo-urethral valve automatically opens and a portion of the urine is released, until the pressure has fallen to a closing value below the critical pressure value, at which the endo-urethral valve closes again.
  • the elastic features of the stopper body, the shape of the gap and the depth thereof, i.e. the extension of the proximal portion of the through slit, where the walls are not in contact with each other even in the open configuration are selected in such a way that the critical pressure value is reasonably higher than a discomfort pressure value at which a normal patient would decide to release urine, but no so high as a limit pressure value at which the patient’s bladder and urethra could be damaged.
  • an intrinsically safe endo-urethral valve is obtained, i.e. one in which an automatic emergency opening is provided controlled by the amount of the urine that is present in the bladder.
  • This automatic endo-urethral valve can be advantageously used to treat a patient who is not able to open endo-urethral valve by himself, for instance, due to a cerebral disease or a therapy or a general anaesthesia or a similar condition, with no risk of bladder or urethra damage due to inner urine overpressure.
  • a catheter not shown, is advantageously provided to remove the urine from the patient’s body.
  • the central portion comprises: an inner part integral to the proximal and distal portions, and an elastic constriction shell arranged about the inner part by a positive-fit connection on an outer surface of the inner part of the central portion, such that the walls of the through slit are maintained in contact to each other, wherein the elastic constriction shell: is configured to be externally pressed by the patient, so as to detach the walls of the through slit and to bring the endo-urethral valve from the closed undeformed configuration to the open deformed configuration; - when arranged about the inner part of the central portion, it has the central transversal dimension of the central portion radially changing between the maximum central transversal dimension and the minimum central transversal dimension.
  • the elastic constriction shell can be provided as a preformed elastic ring or sleeve arranged about the inner part of the central portion.
  • the elastic constriction shell can be made integral to the inner part of the central portion of the endo-urethral valve, for instance, it can be overmolded about the inner part of the central portion.
  • a distal engagement element is arranged to be engaged by a positioning and extraction tool for positioning and/or extracting the endo-urethral valve into/from the patient’s urethra, the distal engagement element comprising: a fastening portion to the endo-urethral valve, incorporated in the distal portion of the endo-urethral valve, and - a grip portion configured to be gripped by the positioning and extraction tool.
  • the grip portion distally protrudes from the distal portion of the endo-urethral valve, which makes it easier to hang the distal engagement element by the positioning and extraction tool.
  • the fastening portion is perimetrically incorporated to said distal tubular portion of the endo-urethral valve, and the grip portion is arranged transversally to the endo-urethral valve between two diametrically opposite regions of the fastening portion.
  • through holes are made through the fastening portion.
  • the strength of the connection between the fastening portion of the distal engagement element and therefore the endo- urethral valve is therefore higher, which prevents any risk of detachment of the fastening element from the body of the endo-urethral valve, in particular, during the extraction of the endo-urethral valve.
  • the maximum overall transversal dimension of the endo-urethral valve in particular a maximum diameter of the endo-urethral valve, excluding the maximum transversal dimension of the central portion, is preferably set between 3 mm and 12 mm, most preferably between 6 mm and 10 mm.
  • the length of the endo-urethral valve is preferably set between 20 mm and 50 mm, in particular between 30 mm and 40 mm, excluding a possible extension and or/stent extending from the proximal end portion to fix the endo- urethral valve within the bladder, at the inlet port of urethra, as described more in detail hereinafter.
  • the endo-urethral valve is made of a material selected from the group consisting of: a silicone i.e. a polysiloxane, in particular polydimethyl siloxane, a polyurethane, polyvinylchloride, an ethylene-vinyl acetate (EVA) copolymer or a derivative thereof, a thermoplastic elastomer, or a combination of the above materials, and said material is moulded in such a way that the walls of the slit, in a rest position, are in contact with each other with a positive pressure against each other.
  • the endo-urethral valve is made of a silicone.
  • the elastic constriction shell can be made of a material selected from the group consisting of: a silicone i.e. a polysiloxane, in particular polydimethyl siloxane, a polyurethane, polyvinylchloride, an ethylene-vinyl acetate (EVA) copolymer or a derivative thereof, a thermoplastic elastomer, or a combination of the above materials, however, the elastic constriction shell is preferably made of the same material as the internal part and the rest of the endo-urethral valve.
  • an endo-urethral valve comprises: a proximal tubular portion and a distal tubular portion arranged along a common longitudinal axis and configured to anchor within a male patient’s urethra and allow a urine to flow therethrough; a central portion arranged between the proximal tubular portion and the distal tubular portion and configured to be pressed by the patient, in order to resiliently change from a closed undeformed configuration to an open deformed configuration, in which the central portion fluid-tightly separates or hydraulically connects, respectively, the proximal tubular portion and the distal tubular portion, wherein the central portion includes a solid stopper body having a proximal side and a distal side mutually spaced apart along the common longitudinal axis of the proximal and distal tubular portions, i.e., the longitudinal axis of the endo-urethral valve, said proximal side and distal side being spaced apart by a longitudinal extension of
  • the through slit having walls mutually facing, wherein the walls in the closed undeformed configuration, are fluid-tightly in contact to each other along the longitudinal extension of the stopper body; are configured to become spaced apart from each other forming a tubular duct along all said longitudinal extension when the central portion changes from the closed undeformed configuration to the open deformed configuration.
  • the central portion consists of a resilient solid cylindrical segment having the longitudinal extension and having the through slit extending for all the longitudinal extension arranged in such a way that when the patient presses the resilient solid cylindrical segment in a plane containing the slit, the slit turns from a configuration in which the walls are in contact with each other fluid tightly to a configuration in which the walls form the tubular duct.
  • the transversal size of the through slit, in the closed configuration is set between 4 and 6 mm, i.e. large enough to allow an easy passage of urine when the through slit is opened to tubular duct by compression from outside.
  • transversal size S is about 5 mm.
  • the longitudinal extension of the solid stopper body which is also the longitudinal extension of the through slit, is longer than the transversal size of the through slit.
  • the length of the solid stopper body, which is also the longitudinal extension of the through slit is set between 6 and 20 mm, i.e., large enough to be easily grasped by two fingers of the patient.
  • the endo-urethral valve is made of a material selected from the group consisting of: a silicone i.e. a polysiloxane, in particular polydimethyl siloxane, a polyurethane, polyvinylchloride, an ethylene-vinyl acetate (EVA) copolymer or a derivative thereof, a thermoplastic elastomer, or a combination of the above materials, and said material is moulded in such a way that the walls of the slit, in a rest position, are in contact with each other with a positive pressure against each other.
  • the endo-urethral valve is made of a silicone.
  • a method to make the above-described endo-urethral valve includes the steps of: forming a draft of the endo-urethral valve, the draft comprising the proximal tubular portion, the distal tubular portion and the inner part of the central portion, by a first step of injection-moulding a first polymeric material in a first mould comprising a first injection chamber, in which a longitudinal core member is fixedly arranged to provide the through slit; arranging the draft into a second mould comprising a second injection chamber configured to surround the inner part of the central portion when the draft is arranged in the second mould; forming an elastic constriction shell about the inner part of the central portion by a second step of injection-moulding a second polymeric material in the second mould, the second injection-moulding step carried out in such a way that the elastic constriction shell engages an outer surface of the inner part of the central portion by a positive-fit connection, such that the walls of
  • an endo-urethral valve is made according to the invention in which no elastic constriction shell
  • a similar method can be carried out providing the following steps: forming a draft of the endo-urethral valve, the draft comprising the proximal tubular portion, the distal tubular portion and the central portion, - injection-moulding of a polymeric material in mould comprising an injection chamber, in which a longitudinal core member is fixedly arranged to provide the through slit; extracting the longitudinal core member obtaining the closed configuration C of the endo-urethral valve.
  • Figs. 1 and 2 diagrammatically show an endo-urethral valve arranged along the urethra of a patient, respectively in a closed configuration and in an open configuration;
  • FIG. 3 and 4 are two perspective views diagrammatically showing an endo-urethral valve according to a first exemplary embodiment of the invention, in a closed configuration;
  • Fig. 5 is a diagrammatical side elevational view of the endo-urethral valve of Figs. 3 and 4;
  • Figs. 6 and 7 are diagrammatical cross-sectional views of the endo- urethral valve of Figs. 3 and 4, the sectional planes being indicated by the lines A-A and B-B of Fig. 5, respectively;
  • Fig. 8 is a diagrammatical perspective view of the endo-urethral valve of Figs. 3 and 4, in an open configuration;
  • Fig. 12 is a diagrammatical perspective view of an endo-urethral valve according to a second exemplary embodiment of the invention
  • - Figs. 13 and 14 are two diagrammatical side views of the endo-urethral valve of Fig. 12, the sectional planes being orthogonal to each other;
  • Figs. 15, 16 and 17 are diagrammatical cross-sectional views of the endo-urethral valve of Fig. 12, the sectional planes being indicated by the lines C-C, D-D, E-E of Fig. 14, respectively; - Figs. 18, 19 and 20 show a diagrammatical perspective view a diagrammatical side view of the endo-urethral valve of Figs. 12-17, in an open configuration;
  • Figs. 21 , 22 and 23 are diagrammatical cross-sectional views of the endo-urethral valve of Fig. 12, in the open configuration of Figs. 19 and 20, the sectional planes being indicated by the lines C-C, D-D, E-E of Fig.
  • Figs. 24 and 25 are diagrammatical cross-sectional views of the endo- urethral valve of Fig. 12, the enlarged view of Fig. 25 showing the effect of the pressure forces applied by the urine contained in a proximal portion of the endo-urethral valve, in the closed configuration;
  • Figs. 26 and 27 are diagrammatical cross-sectional views of an endo- urethral valve according to a third exemplary embodiment of the invention, the enlarged view of Fig. 27 showing the effect of the pressure forces applied by the urine contained in a proximal portion of the endo- urethral valve, in the closed configuration;
  • Fig. 28 is a diagrammatical longitudinal sectional view of an endo-urethral valve according to a fourth exemplary embodiment of the invention, the sectional plane passing through the central longitudinal axis, in a closed configuration of the endo-urethral valve;
  • Figs. 29A and 29B are diagrammatical cross-sectional views of the central portion of the endo-urethral valve of Fig. 28, according to respective exemplary embodiments;
  • Fig. 30 is a diagrammatical longitudinal sectional view of the body of the endo-urethral valve of Fig. 28, without the outer constriction shell;
  • Figs. 31 A and 31 B are diagrammatical cross-sectional views of the central portion of the body of the endo-urethral valve of Fig. 29, according to the exemplary embodiments of Figs. 29A and 29B, respectively;
  • Figs. 32 and 33 are a diagrammatical side view and a diagrammatical bottom view of an endo-urethral valve according to a fifth exemplary embodiment of the invention, in which a distal engagement element is arranged to be engaged by a positioning and extraction tool of the endo- urethral valve;
  • Fig. 34 is a diagrammatical perspective view of the distal engagement element of Figs. 32 and 33;
  • Figs. 35 and 36 are diagrammatical perspective views of first and second moulds used to manufacture an endo-urethral valve according to the invention.
  • Figs. 37 and 38 diagrammatically show endo-urethral valves according to a sixth exemplary embodiment of the invention, in which the proximal tubular end portion comprises a tubular extension and a stent to be fixed within the patient’s bladder;
  • Fig. 39 diagrammatically shows the endo-urethral valve of Figs. 37 or 38 implanted within a male patient’s urethra, in a closed configuration;
  • - Fig 40 is a cross-section of the central portion of the endo-urethral valve of Fig. 28, and of the inner part thereof before mounting the elastic constriction shell thereto;
  • Fig 41 is a cross-section of the central portion of the endo-urethral valve of Fig. 28, and of the elastic constriction shell thereof before being mounted thereto;
  • Fig. 42 is a cross-section of the central portion of the endo-urethral valve of Fig. 28, similar to the cross-sectional views of Figs. 40 and 41 , to explain the effect of the constriction forces applied thereto by the elastic constriction shell;
  • Fig. 43 and 44 are two perspective views diagrammatically showing an endo-urethral valve according to another aspect of the invention, in a closed configuration;
  • Fig. 45 is a diagrammatical side elevational view of the endo-urethral valve of Figs. 43 and 44;
  • Figs. 46 and 47 are diagrammatical cross-sectional views of the endo- urethral valve of Figs. 43 and 44, the sectional planes being indicated by the lines A-A and B-B of Fig. 45, respectively;
  • Fig. 48 is a diagrammatical perspective view of the endo-urethral valve of Figs. 43 and 44, in an open configuration.
  • FIGs. 1 and 2 diagrammatically show an embodiment of an endo- urethral valve 6 according to the invention, implanted within a male patient’s urethra 98.
  • endo-urethral valve 6 is shown in a closed undeformed configuration C (Fig. 1), in which endo-urethral valve 6 prevents urine 90 from flowing out of patient’s bladder 99 through urethra 98.
  • endo-urethral valve 6 is shown in an open configuration in which endo-urethral valve 6 allows urine 90 to flow through urethra 98.
  • Endo-urethral valve 6 is configured to be opened by a compression force F applied to endo-urethral valve 6 by the patient through the tissues of his own penis 97 and through the wall of urethra 98, and is also configured to resiliently close again upon releasing compression force F.
  • Figs. 3-48 show endo-urethral valves 1 , 2, 3, 4, 5, 7, 8, 9 according to different exemplary embodiments of the invention.
  • Endo-urethral valves 1-9 comprise a proximal tubular end portion 10 and a distal tubular end portion 30 both arranged along a common longitudinal axis 11 and configured to anchor within urethra 98 (for example Figs. 1 , 2).
  • Endo-urethral valves 1-9 also comprise a central portion 20 between tubular end portions 10 and 30.
  • Central portion 20 is a stopper portion configured to elastically turn from a closed undeformed configuration C to an open deformed configuration O upon receiving compression force F from the patient.
  • central portion 20 liquid-tightly separates proximal tubular portion 10 and distal tubular portion 30 from each other.
  • central portion 20 hydraulically connects proximal and distal tubular portions 10 and 30 to each other.
  • tubular end portions 10 and 30 can be very short, like short protruding edges.
  • central portion 20 of endo-urethral valves 1 , 2, 3, 4, 5 has a transversal dimension radially changing between a maximum value D2 and a minimum value D1 shorter than D2, as shown in Figs. 6, 15, 29A.
  • central portion 20 includes a solid stopper body 21 having a proximal side 19 and a distal side 29 mutually spaced apart along longitudinal axis 11 by a longitudinal extension B of solid stopper body 21 , and facing proximal and distal portions 10, 30, respectively.
  • Central portion 20 includes a through slit 22 extending between proximal side 19 and distal side 29 and defined by at least one couple of mutually facing walls 23.
  • walls 23 are liquid-tightly in contact to each other along at least one part 27” of longitudinal extension B of stopper body 21 (Figs. 3, 5, 12, 15, 24, 26, 29A-B, 31A-B).
  • walls 23 are also configured to become spaced apart from each other along all longitudinal extension B when central portion 20 turns from closed undeformed configuration C to open deformed configuration O (Figs. 8, 10, 18, 21).
  • FIGs. 3-6 show an endo-urethral valve 1 according to a first exemplary embodiment of the invention, in which the outer surface of central portion 20 has a couple of diametrically protrusions 24 opposite to each other with respect to longitudinal axis 11 of endo-urethral valve 1.
  • Protrusions 24 have top portions 24’ at a predetermined height FI above the outer surface of central portion 20.
  • the height of top portions 24' above the outer surface is longer than or at least equal to 1 mm.
  • the cross-section of silt 22 is preferably linear and has a transversal size S, in closed undeformed configuration C.
  • linear slit 22 is substantially aligned to maximum transversal dimension D2 of central portion 20.
  • the cross-section of slit 22 is aligned to the top portions of diametrically opposite protrusions 24 of central portion 20.
  • transversal size S of slit 22, in closed configuration C is set between 4 and 6 mm, i.e. large enough to allow an easy passage of urine when opened by compression from outside, in particular transversal size S is about 5 mm.
  • length B of solid stopper body 21 , and therefore of through slit 22 is longer than transversal size S of through slit 22.
  • length B of solid stopper body 21 and therefore of through slit 22 is set between 6 and 20 mm.
  • proximal and distal tubular end portions 10,30 are axisymmetric with respect to longitudinal axis 11 , in particular tubular end portions 10,30 have at least an outer cylindrical shape, as shown, for instance, in Figs. 3, 4, 12, 32, and possibly also an inner cylindrical shape.
  • proximal and distal tubular portions 10, 30 have an end transversal dimension T, in particular a diameter T, longer than the maximum central transversal dimension D2 of central portion 20.
  • central portion 20 can be a biaxisymmetric body, i.e. the cross-section of central portion 20 has as a biaxisymmetric shape.
  • the cross section of central portion 20 has a major symmetry axis 26” and a minor symmetry axis 26’, in particular the axes are orthogonal to each other.
  • slit 22 preferably has a linear cross section aligned to major symmetry axis 26”.
  • the cross section of central portion 20 can be a substantially elliptical shape.
  • endo- urethral valve 2 has a proximal/distal tubular connection portion 15,25 between central portion 20 and proximal/distal tubular end portion 10,30, as show for instance in Figs. 13,14,26,28. In this case, as indicated in Figs.
  • tubular connection portion 15,25 gradually turns by from a shape having a symmetry centre to a biaxisymmetric shape from proximal/distal tubular end portion 10, 30 to central portion 20.
  • Figs. 26 and 27 show an endo-urethral valve 3 according to a third exemplary embodiment, in which walls 23 of through slit 22, in closed undeformed configuration C, are fluid-tightly in contact to each other only at a distal part 27” of longitudinal extension B of stopper body 21, and a gap 28 is formed at a proximal part 27’, i.e. walls are at a distance S decreasing towards distal part 27”.
  • Fig. 27 diagrammatically shows pressure forces P that urine 90 applies on the inner walls of proximal part 27’ and on walls 23 of slit 22. Urine pressure forces P are oriented in such a way to detach walls 23.
  • Fig. 25 diagrammatically shows endo-urethral valve 2 of Figs. 13 and 14, in which no gap is provided in the proximal part of through slit 22 and walls 23 of through slit 22, in the undeformed configuration C, are fluid-tightly in contact to each other along all longitudinal extension B of stopper body 21.
  • pressure forces P are applied on the inner walls of proximal part 10 only.
  • the sum of pressure forces P has a transversal component far weaker than in the case of endo-urethral valve 3 of Figs. 26 and 27, and a higher urine pressure is required to open the endo- urethral valve, or the endo-urethral valve could not be open by the urine pressure.
  • gap 28 and the length of proximal part 27’ of slit 22 are selected taking into account the elastic properties of the material of stopper body 21 , and in such a way that the above-mentioned critical pressure value is reasonably higher than a discomfort pressure value at which a normal patient would decide to release urine 90, but not so high as a limit pressure value at which the patient’s bladder 99 and urethra 98 could be damaged.
  • endo-urethral valve 3 automatically opens when the critical pressure value is reached, preventing an excessive pressure to damage the patient’s bladder 99 and urethra 98.
  • a catheter not shown, is advantageously provided to remove urine from the patient’s body.
  • an endo-urethral valve 4 is described according to a fourth exemplary embodiment of the invention.
  • the endo-urethral valve 4 is made of two parts and comprises a draft 4’ and an elastic constriction shell 40 arranged about inner part 20’ of draft 4’, in order to maintain slit 22 and therefore endo-urethral valve 4 in closed undeformed configuration C, as shown in Figs. 28A-29.
  • central portion 20 of endo-urethral valve 4 comprises an inner part 20’ that is manufactured integrally with proximal and distal end portions 10,30, e.g., with proximal and distal connecting portions 15,25.
  • Elastic constriction shell 40 is arranged on an outer surface of inner part 20’ by a positive-fit connection, such that walls 23 of through slit 22 are maintained in contact to each other. Normally, walls 23 cannot be in contact to each other in draft 4’ as manufactured.
  • Elastic constriction shell 40 is configured to be externally pressed by the patient, so as to detach walls 23 of through slit 22 from each other, thus causing endo-urethral valve 4 to resiliently change from closed undeformed configuration C to open deformed configuration O, not shown here but easily understandable by considering, for instance Figs. 20 and 21.
  • the central transversal dimension of elastic constriction shell 40 changes between maximum central transversal dimension D2 and minimum central transversal dimension D1.
  • This can be obtained, for instance, as shown in Fig. 29A, i.e. by fitting a non-uniform-thickness elastic constriction shell 40 about a cylindrical inner part 20’ of central portion 20, or by fitting a uniform-thickness constriction shell 40 about a non-uniform diameter inner part 20’ of central portion 20, such as an inner part 20’ having an elliptical cross section, so that elastic constriction shell 40 is deformed providing the desired uneven transversal dimension of central portion 20.
  • FIG. 40 The effect of elastic constriction shell 40 on inner part 20’ of central portion 20 is shown in Fig. 40, consisting in a compression of inner part 20’ that is stronger in the direction perpendicular to through slit 22 than in the direction of through slit 22 itself, causing mutually facing walls 23 of through slit 22 to close.
  • the elastic behaviour of biaxisymmetric elastic constriction shell 40 is depicted in Fig.41 , i.e. the diameter perpendicular to through slit 22 remain substantially unchanged, while it is shortened in the direction of through slit 22, upon mounting elastic constriction shell 40 about inner part 20’ of central portion 20.
  • Fig. 42 shows the elastic constriction forces FM applied by elastic constriction 40 on inner part 20’ of central portion 20.
  • elastic constriction shell 40 can be made as a preformed elastic ring or sleeve having a predetermined inner size and a predetermined elasticity, which is then fitted about inner part 20’ by a positive- fit connection.
  • Figs. 32 and 33 show an endo-urethral valve 5 according to a fifth exemplary embodiment of the invention, in which a distal engagement element 50 is provided for a tool, not shown, to be used in order to position or extract endo-urethral valve 5 from the patient’s urethra 98 (Figs. 1 ,2), in particular, when replacing the endo-urethral valve.
  • Distal engagement element 50 preferably comprises a fastening portion 51 incorporated or in any case integral in distal tubular end portion 30 of endo-urethral valve 5 and a grip portion 52 configured to engage with a positioning and extraction tool, not shown.
  • distal engagement element 50 can be made of a material different from the rest of endo-urethral valve 5, for example, of a metal or ceramic material, or of a plastic material having a softening point higher than the material of which the rest of endo-urethral valve 5 is formed.
  • distal engagement element 50 can be made of the same material as endo-urethral valve 5, if this material is strong enough, by integral injection moulding in an appropriate mould, not shown.
  • grip portion 52 is arranged transversally, i.e. between two diametrically opposite regions of fastening portion 51 or of distal tubular end portion 30 of endo-urethral valve 5, in this case, grip portion 52 extends along a diameter of distal tubular end portion 30, and preferably protrudes out of distal tubular end portion 30, while fastening portion 51 is perimetrically incorporated in distal tubular end portion 30.
  • Fig. 34 shows an exemplary embodiment of distal engagement element 50, in which through holes 55 are made in the fastening portion 51 , in order to assist anchoring of fastening portion 51 within the wall of distal tubular end portion 30.
  • both fastening portion 51 of distal engagement element 50 and distal tubular end portion 30 have a cylindrical shape.
  • the overall or maximum transversal dimension K of the endo- urethral valve according to the exemplary embodiments of the invention, among which the ones shown in the drawings (Figs. 5, 13 and 14), in particular a maximum diameter K, is set between 3 mm and 12 mm, in particular between 6 mm and 10 mm.
  • the endo-urethral valve according to the various exemplary embodiments of the invention has a length L (Figs. 5, 13 and 14) preferably set between 20 mm and 50 mm, in particular between 30 mm and 40 mm.
  • the endo-urethral valve is made of a biocompatible material. This material can be selected from the group consisting of a silicone, i.e.
  • a polysiloxane in particular polydimethyl siloxane, a polyurethane, polyvinylchloride, an ethylene-vinyl acetate (EVA) copolymer or a derivative thereof, a thermoplastic elastomer, or a combination of these materials, but preferably the material of the endo-urethral valve is a silicone.
  • elastic constriction shell 40 is made of a material selected from the group consisting of: a silicone, i.e. a polysiloxane, in particular polydimethyl siloxane, a polyurethane, polyvinylchloride, a thermoplastic elastomer, or a combination of these materials, but preferably the material of elastic constriction shell 40 is a silicone.
  • elastic constriction shell 40 can be made in the same material as inner part 20’ of central portion 20 of draft 4’.
  • proximal tubular end portion 10 of endo-urethral valve 7,8 can also comprise a tubular extension 17 and possibly a stent 18 of known type configured to be fixed within bladder 99, at the inlet port of urethra 98, as shown in Fig. 39.
  • Tubular extension 17 can be integrally manufactured with the rest of endo-urethral valve 7,8 or can be mounted to a pre-formed endo- urethral valve after a forming step thereof, as a separate part.
  • the rest of proximal portion 10 and tubular extension 17 comprise mutual connection means preferably of snap-fit type or positive engagement type.
  • stopper body 20 can extend up to the end of distal tubular end portion 30 and endo-urethral valve 8 can be configured to be cut at a cut line 20” to adjust the overall length of endo- urethral valve 8 to the length of patient’s urethra 98, so that stopper portion 20, when endo-urethral valve 8 is implanted, is present at a mid-section of the patient’s penis to be comfortably compressed by the patient and opened.
  • An endo-urethral valve 9 is basically shown in Figs. 43-48, including a proximal tubular end portion 10 and a distal tubular end portion 30 both arranged along a common longitudinal axis 11 and configured to anchor within urethra 98 (Figs. 1, 2).
  • Endo-urethral valve 9 also comprise a central portion 20 between tubular end portions 10 and 30.
  • Central portion 20 is a stopper portion configured to elastically turn from a closed undeformed configuration C (Fig. 43) to an open deformed configuration O (Fig. 48) upon receiving compression force F from the patient.
  • closed undeformed configuration C central portion 20 liquid- tightly separates proximal tubular portion 10 and distal tubular portion 30 from each other.
  • open deformed configuration O central portion 20 hydraulically connects proximal and distal tubular portions 10 and 30 to each other.
  • central portion 20 includes a solid stopper body 21 having a proximal side 19 and a distal side 29 mutually spaced apart along longitudinal axis 11 by a longitudinal extension B of solid stopper body 21 , and facing proximal and distal portions 10, 30, respectively.
  • Central portion 20 includes a through slit 22 extending between proximal side
  • walls 23 are liquid-tightly in contact to each other along at least one part of longitudinal extension B of stopper body 21. Moreover, walls 23 are also configured to become spaced apart from each other along all longitudinal extension B when central portion
  • the cross-section of silt 22 is preferably linear, in closed undeformed configuration C.
  • proximal, central and distal tubular end portions 10,20,30 are axisymmetric with respect to longitudinal axis 11, in particular they have at least an outer cylindrical shape, as shown in the exemplary embodiment of Figs. 43, 44, and possibly also an inner cylindrical shape.
  • endo-urethral valves 3 Figs 26 and 27
  • 4 Figs. 28-31 B
  • 5 Figs. 32-34
  • 7 Fig. 37
  • 8 Fig. 28
  • the endo-urethral valve of the invention can be manufactured by a process including injection moulding steps.
  • the present invention also includes a method to manufacture endo- urethral valve 4 (Figs. 28-31 B) according to an embodiment of the one aspect invention, as well as an endo-urethral valve, not shown, according to a corresponding exemplary embodiment of the other aspect of the invention, in particular, if constriction shell 40 is made integral to inner part 20’ of central portion 20, in particular, is overmolded about inner part 20’.
  • the method provides a first step of forming a draft 4’ by moulding, in particular by injection moulding. As described above, draft 4’ comprises proximal tubular portion 10, distal tubular portion 30 and an inner part 20’ of central portion 20.
  • the first step of forming draft 4’ can be carried out in a first mould 60 as shown in Fig. 35, by an injection-moulding process of a first biocompatible polymeric material that is preferably a silicone, i.e. a polysiloxane, in particular polydimethyl siloxane, or even a material selected among polyurethanes, polyvinylchloride, thermoplastic elastomers, or a combination of at least two out of all these materials.
  • a first biocompatible polymeric material that is preferably a silicone, i.e. a polysiloxane, in particular polydimethyl siloxane, or even a material selected among polyurethanes, polyvinylchloride, thermoplastic elastomers, or a combination of at least two out of all these materials.
  • the first mould 60 comprises two removable heads 62 and 63 and a couple of shell portions 66 arranged to form a first injection chamber 67 having for example a shape corresponding to the shape of endo-urethral valve 2, or of an endo-urethral valve according to any of the exemplary embodiments described herein. Mould 60 can be closed by conventional lock means such as screws, for which through holes 68,68’ are longitudinally made through heads 62,63 and shell portions 66, respectively.
  • Support elements 65 for a longitudinal core 61 extend within first injection chamber 67 from a central position of heads 62,63, so that longitudinal core 61 can be arranged within first injection chamber 67 while injection-moulding endo-urethral valve 2, in order to form slit 22.
  • An injection channel 64 allows a polymeric material to be injected into first injection chamber 67.
  • a means of conventional type is also provided for adjusting the temperature of first mould 60, as well as a conventional injection control means, not shown.
  • Second mould 70 also comprises two heads 73, one of which only is shown for the sake of clearness, and shell elements 75, 76, which can be mounted to each other to define an inner space 71.
  • the end portions of inner space 71 are conformed to come into contact with tubular end portions 10, 20 and tubular connection portions 15, 25 of draft 4’, while a central portion of inner space 71 is a second injection chamber 77 configured to surround only inner part 20’ of central portion 20 of draft 4’, once the latter has been arranged into inner space 71 before closing second mould 70.
  • shell elements 75, 76 can be assembled with heads 73 by conventional lock means as screws, for which longitudinal through holes 78,78’ are provided through heads 73 and shell portions 75,76.
  • an injection channel 74 allows a second polymeric material, selected among the above- mentioned materials, to be injected second injection chamber 77.
  • a means of conventional type is also provided for adjusting the temperature of second mould 70, as well as a conventional injection control means, not shown.
  • second injection chamber 77 has a width variable from a minimum value, at a first transversal axis, to a maximum value, at a second transversal axis, in particular first and second transversal axes are perpendicular to each other. This way, at the first transversal axis, the width of second injection chamber 77 is larger than at second transversal axis, and therefore at the first transversal axis, in order to form a variable-thickness elastic constriction shell 40 as shown in Fig. 29A.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Saccharide Compounds (AREA)

Abstract

Une valve endo-urétrale (4) comprend des parties d'extrémité tubulaires (10, 30) pour fixer la valve à l'intérieur de l'urètre d'un patient mâle (98) et une partie centrale (20) disposée entre les parties d'extrémité et comprenant un corps de bouchon solide (21) qui présente une extension longitudinale (B), un côté proximal (19) et un côté distal (29) espacés mutuellement le long d'un axe longitudinal (11) de ladite extension longitudinale (B), le corps de bouchon solide (21) comprenant une fente traversante (22) de préférence linéaire s'étendant pour toute ladite extension longitudinale (B) entre le côté proximal (19) et le côté distal (29), la fente traversante (22) ayant des parois se faisant mutuellement face (23) conçues pour passer élastiquement d'une configuration fermée non déformée (C) à une configuration déformée ouverte (O) sous l'action d'une force de compression par le patient à travers les tissus de son pénis et de la paroi de l'urètre. Dans un aspect de l'invention, dans la configuration fermée non déformée (C), la partie centrale (20) présente une dimension transversale centrale variable entre des valeurs minimales (D1) et maximales (D2), de manière à permettre au patient d'identifier rapidement la direction selon laquelle la force de compression doit être appliquée pour ouvrir la valve.
PCT/IB2022/051757 2021-02-26 2022-02-28 Valve endo-urétrale Ceased WO2022180620A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102021000004631 2021-02-26
IT102021000004631A IT202100004631A1 (it) 2021-02-26 2021-02-26 Valvola endouretrale

Publications (1)

Publication Number Publication Date
WO2022180620A1 true WO2022180620A1 (fr) 2022-09-01

Family

ID=76034939

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2022/051757 Ceased WO2022180620A1 (fr) 2021-02-26 2022-02-28 Valve endo-urétrale

Country Status (2)

Country Link
IT (1) IT202100004631A1 (fr)
WO (1) WO2022180620A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202300005136A1 (it) * 2023-03-17 2024-09-17 Relief S R L Valvola endouretrale con lunghezza modulabile
WO2024194788A1 (fr) 2023-03-17 2024-09-26 Relief S.R.L. Prothèse endo-uréthale et soupape et jeu pour prothèse endo-uréthale

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965925A (en) * 1974-03-18 1976-06-29 J. H. Gooch & Company Limited Pinch valve
US4932938A (en) 1989-05-05 1990-06-12 Medical Engineering Corporation Urethral indwelling catheter with incontinence control
US4968294A (en) 1989-02-09 1990-11-06 Salama Fouad A Urinary control valve and method of using same
US5800339A (en) 1989-02-09 1998-09-01 Opticon Medical Inc. Urinary control valve
WO1999004187A1 (fr) * 1997-07-15 1999-01-28 Unilever Plc Clapet en bec de canard
US5954766A (en) 1997-09-16 1999-09-21 Zadno-Azizi; Gholam-Reza Body fluid flow control device
US6022312A (en) 1995-05-05 2000-02-08 Chaussy; Christian Endosphincter, set for releasable closure of the urethra and method for introduction of an endosphincter into the urethra
US7008372B2 (en) 2002-11-30 2006-03-07 Willy Rüsch GmbH Artificial endosphincter
US20070276342A1 (en) * 2006-03-28 2007-11-29 Bryant Lin Devices and related methods for treating incontinence
WO2014090227A1 (fr) 2012-12-14 2014-06-19 Medicoplast International Gmbh Endosphincter
US20170020645A1 (en) 2009-12-18 2017-01-26 Coloplast A/S Method of treating urinary incontinence
US9763762B2 (en) * 2013-09-25 2017-09-19 Medtronic, Inc. Implantable urinary tract valve

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965925A (en) * 1974-03-18 1976-06-29 J. H. Gooch & Company Limited Pinch valve
US4968294A (en) 1989-02-09 1990-11-06 Salama Fouad A Urinary control valve and method of using same
US5800339A (en) 1989-02-09 1998-09-01 Opticon Medical Inc. Urinary control valve
US4932938A (en) 1989-05-05 1990-06-12 Medical Engineering Corporation Urethral indwelling catheter with incontinence control
US6022312A (en) 1995-05-05 2000-02-08 Chaussy; Christian Endosphincter, set for releasable closure of the urethra and method for introduction of an endosphincter into the urethra
WO1999004187A1 (fr) * 1997-07-15 1999-01-28 Unilever Plc Clapet en bec de canard
US5954766A (en) 1997-09-16 1999-09-21 Zadno-Azizi; Gholam-Reza Body fluid flow control device
US7008372B2 (en) 2002-11-30 2006-03-07 Willy Rüsch GmbH Artificial endosphincter
US20070276342A1 (en) * 2006-03-28 2007-11-29 Bryant Lin Devices and related methods for treating incontinence
US20170020645A1 (en) 2009-12-18 2017-01-26 Coloplast A/S Method of treating urinary incontinence
WO2014090227A1 (fr) 2012-12-14 2014-06-19 Medicoplast International Gmbh Endosphincter
US9763762B2 (en) * 2013-09-25 2017-09-19 Medtronic, Inc. Implantable urinary tract valve

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202300005136A1 (it) * 2023-03-17 2024-09-17 Relief S R L Valvola endouretrale con lunghezza modulabile
EP4431057A1 (fr) 2023-03-17 2024-09-18 Relief S.R.L. Kit pour prothèse endo-urétrale avec valve
WO2024194788A1 (fr) 2023-03-17 2024-09-26 Relief S.R.L. Prothèse endo-uréthale et soupape et jeu pour prothèse endo-uréthale

Also Published As

Publication number Publication date
IT202100004631A1 (it) 2022-08-26

Similar Documents

Publication Publication Date Title
US10780243B2 (en) Method and apparatus for treatment of human urinary incontinence
US6119697A (en) Device for the treatment of male and female urinary incontinence
US3592197A (en) Catheter
US20050119672A1 (en) Gastric ring made of variable hardness elastomeric material
US5707357A (en) Balloon catheter having palpitatable discharge valve and retention collar
US6167886B1 (en) Device for treatment of male and female urinary incontinence
EP1434616B1 (fr) Dispositifs de drainage anti-reflux et procedes associes
US8721522B2 (en) Dual balloon gastric ring
CN102802713B (zh) 一种导尿管和用于注射成型所述导尿管的方法
TWI668024B (zh) 可引流體內積液之導管
WO2022180620A1 (fr) Valve endo-urétrale
US9950138B2 (en) Indwelling urinary catheter
KR101501445B1 (ko) 요관 스텐트 및 요관 스텐트의 제조방법
US20250276151A1 (en) Urinary catheter for controlled drainage
WO2009000081A1 (fr) Dispositif de régulation de la pression dans l'urètre destiné à lutter contre l'incontinence
WO1996002214A1 (fr) Catheter urinaire
KR20060072153A (ko) 음경 임플란트 디바이스용 유체저장기 및 그 제조방법
JP7216712B2 (ja) 尿失禁治療のための尿道プラグおよびシステム
US20020133053A1 (en) Intraurethral device for incontinence
WO2024215922A1 (fr) Valve d'étanchéité et de remplissage de ballonnet
CN105358094B (zh) 诸如失禁装置的尿液流动控制装置
US12144713B2 (en) Male incontinence control device and method of controlling male incontinence
WO2025088218A1 (fr) Dispositif de régulation de débit urinaire
IT202300005136A1 (it) Valvola endouretrale con lunghezza modulabile
KR20130062696A (ko) 음경 보형물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22712050

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 17.01.2024)

122 Ep: pct application non-entry in european phase

Ref document number: 22712050

Country of ref document: EP

Kind code of ref document: A1